InvestorsObserver is giving Forma Therapeutics Holdings Inc (FMTX) an Analyst Rating Rank of 16, meaning FMTX is ranked higher by analysts than 16% of stocks. The average price target for FMTX is $20.75 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating FMTX a Buy today. Find out what this means to you and get the rest of the rankings on FMTX!